PREMIER Biosoft logo  
Home >> Company >> News >> Primer Premier 6.00 Release
PREMIER Biosoft Facebook link PREMIER Biosoft Twitter link

PREMIER Biosoft International releases Primer Premier 6.00 with support for automatic sequence retrieval, homology and template structure avoidance, compatible primer search and multiplex design

Palo Alto, California -- December 04, 2009 - PREMIER Biosoft International today announced the world wide release of Primer Premier version 6.00. Primer Premier will now enable users to design highly specific standard PCR and SNP genotyping assays. Primer Premier now employs a powerful algorithm to avoid homology and template secondary structures regions to aid in providing specificity to the primers.

For multiplexing, Primer Premier launches a primer search in batch mode. Primer Premier checks for all the possible cross reactivity and displays the most stable structure formed by each primer. This functionality reduces false priming and ensures a strong signal strength.

In addition to the above, it enables the use of pre-designed, well proven primers and designs a compatible set, given any one primer, forward or reverse. Users can design SNP flanking primers for SNP genotyping assays.

"Primer Premier 6 is a powerful tool for designing highly specific standard PCR assays. We are committed to keeping pace with the needs of research by constantly adding advance and powerful features to our products," commented Kay Brown, V.P. Business Development and Marketing.

For details, please visit:

About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International can be found at

Arun Apte
PREMIER Biosoft International

Copyright ©1994- PREMIER Biosoft. All rights reserved.